Literature DB >> 26541589

[The "obese" and "old" male patient in dermatological practice. When should hypogonadism be considered?].

D Varwig-Janßen1, F Ochsendorf2.   

Abstract

Hypogonadism refers to reduced endocrine function of the testicles and leads to testosterone deficiency. It is often observed in older and obese men. Symptoms with the highest predictive value are reduced sexual thoughts, decreased spontaneous erections, and erectile dysfunction. After excluding contraindications (e.g., desire for children), various forms of replacement therapy are available. Studies have shown that testosterone therapy is safe if regularly checked.

Entities:  

Keywords:  Diabetes mellitus; Erectile dysfunction; Metabolic syndrome; Obesity; Testosterone

Mesh:

Substances:

Year:  2015        PMID: 26541589     DOI: 10.1007/s00105-015-3716-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  34 in total

1.  Identification of late-onset hypogonadism in middle-aged and elderly men.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Jennifer M Beynon; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Michael E J Lean; Neil Pendleton; Margus Punab; Steven Boonen; Dirk Vanderschueren; Fernand Labrie; Ilpo T Huhtaniemi
Journal:  N Engl J Med       Date:  2010-06-16       Impact factor: 91.245

2.  Breast cancer and long-term hormonal treatment of male hypogonadism.

Authors:  Marek Medras; Alicja Filus; Paweł Jozkow; Pawel Jozkow; Jacek Winowski; Teresa Sicinska-Werner; Teresa Sicinska Werner
Journal:  Breast Cancer Res Treat       Date:  2006-01-18       Impact factor: 4.872

Review 3.  The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy.

Authors:  Julia Klap; Marianne Schmid; Kevin R Loughlin
Journal:  J Urol       Date:  2014-09-28       Impact factor: 7.450

4.  Prolactin-screening tumors and hypogonadism in 22 men.

Authors:  J N Carter; J E Tyson; G Tolis; S Van Vliet; C Faiman; H G Friesen
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

Review 5.  Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis.

Authors:  Giovanni Corona; Elisa Maseroli; Giulia Rastrelli; Andrea M Isidori; Alessandra Sforza; Edoardo Mannucci; Mario Maggi
Journal:  Expert Opin Drug Saf       Date:  2014-08-19       Impact factor: 4.250

Review 6.  Phenotypic heterogeneity of mutations in androgen receptor gene.

Authors:  Singh Rajender; Lalji Singh; Kumarasamy Thangaraj
Journal:  Asian J Androl       Date:  2007-03       Impact factor: 3.285

Review 7.  Critical Update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism: A Systematic Analysis.

Authors:  Allen D Seftel; Martin Kathrins; Craig Niederberger
Journal:  Mayo Clin Proc       Date:  2015-07-20       Impact factor: 7.616

8.  Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement.

Authors:  William Rosner; Richard J Auchus; Ricardo Azziz; Patrick M Sluss; Hershel Raff
Journal:  J Clin Endocrinol Metab       Date:  2006-11-07       Impact factor: 5.958

9.  Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe Casanueva; Gianni Forti; Aleksander Giwercman; Ilpo T Huhtaniemi; Krzysztof Kula; Margus Punab; Steven Boonen; Dirk Vanderschueren
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

Review 10.  Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review.

Authors:  Farid Saad; Antonio Aversa; Andrea M Isidori; Louis J Gooren
Journal:  Curr Diabetes Rev       Date:  2012-03
View more
  1 in total

Review 1.  [Andrology in oncological diseases].

Authors:  T Weberschock; S Grunewald; F Ochsendorf
Journal:  Hautarzt       Date:  2018-12       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.